Methyl N-Boc-4-hydroxypiperidine-3-carboxylate, 95.0%, 10g

2-[7-(tert-Butyl)pyren-2-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)5g

4-CHLORO-1H-INDAZOL-5-OL, 95%, 1g

2,6-Bis(trifluoromethyl)benzonitrile, 98.0%, 5g

ethyl 4-oxo-4-[2-(piperidinomethyl)phenyl]butyrate, 97.0%, 1g

2,3-Dichloro-2'-morpholinomethyl benzophenone, 97.0%, 1g

2,2,3,3-Tetrafluoro-3-[[1,1,1,2,3,3-hexafluoro-3-[(1,2,2-trifluorovinyl)oxy]propan-2-yl]oxy]propionitrile>93.0%(GC)25g

METHYL 2-(METHYLAMINO)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)NICOTINATE, 95%, 100mg

Iode, min 99,8 %, pa, ACS, resublimé, 100 g, emballage verre

2-(2-Amino-1,3-thiazol-4-yl)-N-methylacetamide, 95.0%, 500mg

4-(3-Bromophenyl)azetidin-2-one, 98%, 500mg

Meisoindigo>98.0%(HPLC)25mg

N'-Hydroxyimidazo[1,2-a]pyridine-2-carboximidamide, 95.0%, 250mg